Kraj: Irlandia
Język: angielski
Źródło: HPRA (Health Products Regulatory Authority)
Nitrofurantoin
Amdipharm Limited
J01XE; J01XE01
Nitrofurantoin
100 milligram(s)
Capsule, hard
Nitrofuran derivatives; nitrofurantoin
Marketed
1977-04-01
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT MACRODANTIN ® 50MG AND 100MG CAPSULES, HARD nitrofurantoin READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor, pharmacist or nurse. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any of the side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. The name of your medicine is Macrodantin 50mg and 100mg Capsules, hard. It will be referred to as Macrodantin Capsules for ease hereafter. WHAT IS IN THIS LEAFLET: 1. What Macrodantin Capsules are and what they are used for 2. What you need to know before you take Macrodantin Capsules 3. How to take Macrodantin Capsules 4. Possible side effects 5. How to store Macrodantin Capsules 6. Contents of the pack and other information 1. WHAT MACRODANTIN CAPSULES ARE AND WHAT THEY ARE USED FOR Nitrofurantoin (the active substance in Macrodantin Capsules) is an antibiotic. It is used to prevent and treat infections of the bladder, kidney and other parts of the urinary tract. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE MACRODANTIN CAPSULES DO NOT TAKE MACRODANTIN CAPSULES: If you are allergic to nitrofurantoin or any of the ingredients of this medicine (listed in Section 6) If you are allergic to other nitrofuran If you have been advised by your doctor that you have a low kidney function (eGFR less than 45ml per minute) If you are in the final stages of pregnancy (labour or delivery) or breast-feeding or in babies under three months of age, as there is a risk that it might affect the baby If you lack an enzyme (body chemical) called glucose-6- phosphate dehydrogenase, which causes your red blood cells to be more easily damaged (this is more common in black p Przeczytaj cały dokument
Health Products Regulatory Authority 12 May 2021 CRN00C7Y2 Page 1 of 8 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Macrodantin 100mg Capsules, hard 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains 100 mg Nitrofurantoin. Excipient with known effect: Each capsule contains 207.0mg lactose monohydrate. _For the full list of excipients, see section 6.1._ 3 PHARMACEUTICAL FORM Capsule, hard (capsule) Hard gelatin capsule with an opaque yellow cap and body, containing a pale yellow odourless powder in macrocrystalline form. The capsules are printed with the logo 'Eaton 009' in edible black ink on both body and cap. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the treatment of and prophylaxis against acute or recurrent, uncomplicated lower urinary tract infections or pyelitis either spontaneous or following surgical procedures. Nitrofurantoin is specifically indicated for the treatment of infections when due to susceptible strains of _Escherichiacoli_, Enterococci, Staphylococci, Citrobacter, Klebsiella and Enterobacter. Most strains of Proteus and Serratia are resistant. All Pseudomonas strains are resistant. Macrodantin is not indicated for the treatment of associated renal cortical or perinephric abscesses (see section 5.1). Consideration should be given to official guidance on the appropriate use of antibacterial agents. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Indication Age group Dose regimen Duration Acute Urinary Tract Infections Children over the age of three months 3 mg/kg/day in four divided doses 7 days Acute uncomplicated urinary tract Infections Children over the age of 10 and Adults (18 – 64 years) 50mg four times daily 7 days Elderly (65 years and over)* 50mg four times daily Severe chronic recurrent infections** Children over the age of 10 and Adults (18 – 64 years) 100 mg four times daily** 7 days Elderly (65 years and over)* Long Term suppressive therapy*** Children over the age of 10 and Adults (18 – 64 years) 50 Przeczytaj cały dokument